drugset / Trial / NCT01118819
Safety Study of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This protocol will examine the safety of intravenous administration of Clostridium novyi-NT spores in patients with treatment-refractory solid tumor malignancies. This investigational study will measure anti-tumor activity of C. novyi-NT administered intravenously in patients with treatment-refractory solid tumor malignancies.
Timeline
- Start
- 2011-04
- Primary completion
- 2013-06
- Completion
- 2013-06
Outcome
Outcome not reported
Stopped: “This study was terminated. An IT injection study of C. novyi-NT in patients with treatment refractory solid tumor malignancies may be viewed at NCT01924689.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clostridium novyi-NT spores | Unknown | 100000 unknown | Intravenous |
| Subject | Clostridium novyi-NT spores | Unknown | 1e+07 unknown | Intravenous |
Indications
No indication recorded.